Manufacturers Life Insurance Company, The Pliant Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 21,223 shares of PLRX stock, worth $28,863. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,223
Previous 74,826
71.64%
Holding current value
$28,863
Previous $985,000
97.16%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding PLRX
# of Institutions
154Shares Held
62.2MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$8.16 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.4MShares$7.34 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$6.76 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$4.54 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.05MShares$4.15 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $66.2M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...